Author: Dr Najeeb Arbani

Dr. Najeeb Arbani is an experienced physician, clinical researcher, and medical writer dedicated to providing evidence-based, highly accurate medical information. With years of experience in clinical practice and healthcare education, he specializes in translating complex clinical trials, medical research, and metabolic science into practical, easy-to-understand guidance. Dr. Arbani is committed to upholding the highest standards of integrity and E-E-A-T (Experience, Expertise, Authoritativeness, and Trustworthiness) across all health and wellness publications.

Microplastics Human Bloodstream Infiltration: Vascular Endothelial Accumulation, Cytotoxicity, and Clinical Toxicology Frontiers – Clinical Evidence & Healthcare Analysis The ubiquity of synthetic polymer contamination has crossed a critical threshold in human environmental toxicology, transitioning from an ecological hazard restricted to marine ecosystems into an invasive systemic internal pollutant. Landmark clinical investigations utilizing ultra-sensitive analytical spectroscopy have confirmed the presence of microplastic and nanoplastic particles within human whole blood, surgical vascular thrombi, atheromatous plaques, placenta, and deep parenchymal tissues. This revelation challenges longstanding assumptions regarding the impermeability of human epithelial barriers and raises profound questions regarding systemic vascular toxicity. Once inhaled…

Read More

Global Antimicrobial Stewardship Mandates: Carbapenem-Resistant Pathogen Surveillance and Novel Beta-Lactamase Inhibitor Pipelines – Clinical Evidence & Healthcare Analysis Antimicrobial resistance (AMR) has escalated into one of the most formidable public health emergencies of the twenty-first century, threatening to erode nearly a century of medical progress achieved since the discovery of penicillin. The global dissemination of multidrug-resistant (MDR) and extensively drug-resistant (XDR) bacterial pathogens – particularly carbapenem-resistant Enterobacterales (CRE), multidrug-resistant Pseudomonas aeruginosa, and carbapenem-resistant Acinetobacter baumannii (CRAB) – poses an existential threat to modern healthcare systems, compromising the safety of routine surgical procedures, organ transplantation, and intensive cancer chemotherapy across the…

Read More

Autonomic Nervous System Heart Rate Variability: Parasympathetic Resiliency, Overtraining Biomarkers, and Sleep Architecture – Clinical Evidence & Healthcare Analysis Heart rate variability (HRV) has emerged as one of the most vital non-invasive biomarkers in modern exercise physiology, clinical cardiology, and sports neurobiology, offering an objective window into the real-time regulatory balance of the human autonomic nervous system (ANS). Contrary to the intuitive assumption that a healthy resting heart beats with rigid metronomic precision, a healthy cardiovascular system displays profound beat-to-beat variability in the intervals between successive heartbeats (R-R intervals). This dynamic fluctuation reflects the constant push-pull interplay between the decelerating…

Read More

High-Altitude Hypoxia Training Adaptations: Erythropoietin Kinetics, Capillarization, and Ventilatory Acclimatization – Clinical Evidence & Healthcare Analysis High-altitude hypoxia training represents one of the most rigorously investigated ergogenic paradigms in environmental physiology and elite endurance athletics, designed to harness the body’s profound homeostatic adaptations to reduced ambient oxygen availability. At sea level, atmospheric pressure of 760 mmHg produces an inspired oxygen partial pressure (PiO2) of approximately 150 mmHg; however, as elevation ascends, barometric pressure decreases exponentially, producing hypobaric hypoxia. Although the fractional concentration of atmospheric oxygen remains invariant at 20.93 percent, the diminished driving pressure across the alveolar-capillary membrane drastically compromises…

Read More

Neuromuscular Tendinopathy Rehabilitation: Isometric Loading, Tendon Collagen Remodeling, and Eccentric Protocols – Clinical Evidence & Healthcare Analysis Tendinopathy represents one of the most pervasive, debilitating musculoskeletal disorders encountered in modern sports medicine, orthopedics, and clinical physical therapy, affecting elite athletic populations and sedentary individuals alike. Characterized clinically by localized, load-dependent tendon pain, impaired mechanical load-bearing capacity, morning stiffness, and profound functional disability, tendinopathy predominantly afflicts high-demand energy storage and transmission structures, including the patellar tendon, Achilles tendon, common extensor tendon of the lateral elbow, and the rotator cuff supraspinatus tendon. For decades, clinical management was fundamentally misled by the erroneous…

Read More

Hypertrophy Muscle Protein Synthesis: Mechanical Tension, Satellite Cell Activation, and Periodization Science – Clinical Evidence & Healthcare Analysis Skeletal muscle hypertrophy represents one of the most remarkable physiological adaptations in human biology, characterized by an expansion of muscle cross-sectional area driven by the net accretion of contractile myofibrillar proteins within multinucleated muscle fibers. Skeletal muscle mass is governed by a continuous, dynamic metabolic equilibrium between muscle protein synthesis (MPS) and muscle protein breakdown (MPB). In the basal, post-absorptive state, net protein balance is chronically negative; however, the synergistic combination of high-intensity mechanical overload and targeted hyperaminoacidemia stimulates a profound, sustained…

Read More

Chronic Kidney Disease Hemodialysis Architecture: Vascular Access, Peritoneal Dialysis, and Electrolyte Homeostasis – Clinical Evidence & Healthcare Analysis Chronic kidney disease (CKD) represents a catastrophic global public health challenge, characterized by progressive, irreversible loss of renal nephron architecture, impaired glomerular filtration, and the systemic accumulation of toxic uremic retention solutes. As renal functional reserve steadily declines through stages 1 through 5, patients experience severe perturbations in extracellular fluid volume, systemic arterial hypertension, mineral and bone disorder (CKD-MBD), refractory normocytic anemia, and life-threatening acid-base and electrolyte derangements. When end-stage renal disease (ESRD / CKD Stage 5D) supervenes – defined clinically by…

Read More

Systemic Lupus Erythematosus Diagnosis: Autoantibody Profiling, Renal Involvement, and Biologic Interventions – Clinical Evidence & Healthcare Analysis Systemic lupus erythematosus (SLE) represents the quintessential systemic autoimmune syndrome, characterized by profound loss of immunological self-tolerance, persistent polyclonal B-cell hyperactivity, abnormal T-cell signaling, defective clearance of apoptotic nuclear debris, and the widespread formation and tissue deposition of pathogenic immune complexes. Because SLE can affect virtually any organ system in the human body – ranging from benign cutaneous discoid lesions and symmetric non-erosive polyarthritis to life-threatening lupus nephritis, neuropsychiatric lupus, and severe autoimmune cytopenias – its clinical presentation is notoriously heterogeneous. This extraordinary…

Read More

Non-Alcoholic Fatty Liver Disease Progression: NASH Biomarkers, Fibrosis Staging, and Metabolic Resection Management – Clinical Evidence & Healthcare Analysis Non-alcoholic fatty liver disease (NAFLD) – recently reclassified in international consensus nomenclature as metabolic dysfunction-associated steatotic liver disease (MASLD) – has emerged as the most prevalent chronic liver disease worldwide, affecting approximately 30 to 38 percent of the global adult population. Driven predominantly by the worldwide epidemics of type 2 diabetes mellitus, visceral adiposity, and metabolic syndrome, the disease spectrum spans a broad pathological continuum. This trajectory extends from simple, clinically quiescent hepatic steatosis (isolated triglyceride accumulation within hepatocytes) to active…

Read More

Cardiovascular Atherosclerosis Pathophysiology: Plaque Vulnerability, Lipid Lowering Therapies, and Stent Technologies – Clinical Evidence & Healthcare Analysis Cardiovascular atherosclerosis remains the preeminent cause of morbidity and mortality across developed and developing nations alike, presenting an escalating clinical burden that demands rigorous understanding of vascular cell biology, arterial biomechanics, and targeted pharmacological intervention. Far from being a simplistic, passive accumulation of dietary lipids within the arterial conduit, modern vascular biology recognizes atherogenesis as an active, chronic, immunologically driven fibro-inflammatory disorder orchestrated by continuous crosstalk between circulating lipoproteins, activated endothelial cells, monocyte-derived macrophages, vascular smooth muscle cells, and the extracellular matrix. The…

Read More